Physician profile
Steven A Feher
NPI 1851431316
$49,967.39
in general payments reported to CMS, 2019-2025
25 companies · $7,321 in 2025
The $7,321 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,521 · 2020: $1,408 · 2021: $10K · 2022: $3,252 · 2023: $14K · 2024: $6,391 · 2025: $7,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $7,471 · Travel and Lodging: $3,444 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,467.01 |
| Food and Beverage | $7,470.78 |
| Travel and Lodging | $3,444.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,575.10 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $16,247.24 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $1,525.84 | 2020-2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial, Gore Cardioform Septal Occluder |
| Becton, Dickinson and Company | $1,100.41 | 2025 | Phasix Mesh |
| Davol INC. | $806.80 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Tas Medical, INC. | $694.76 | 2024 | |
| Conmed Corporation | $384.97 | 2023-2025 | Airseal, Conmed Trocars |
| Polynovo North America LLC | $351.98 | 2023-2025 | Novosorb Btm |
| Kerecis Limited | $272.64 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $243.74 | 2019-2021 | |
| Allergan, INC. | $236.05 | 2019-2022 | |
| Biocomposites INC | $79.67 | 2025 | Stimulan |
| Covidien LP | $76.42 | 2019 | |
| Tei Biosciences INC | $61.85 | 2019 | |
| Ethicon US, LLC | $57.47 | 2020-2025 | Vistaseal |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $49.13 | 2021 | |
| Baxter Healthcare | $33.61 | 2025 | Perclot |
| Currax Pharmaceuticals LLC | $31.54 | 2021-2022 | |
| Teleflex LLC | $27.08 | 2025 | Deknatel |
| Vertex Pharmaceuticals Incorporated | $27.01 | 2025 | |
| Organogenesis INC. | $19.68 | 2021 | |
| La Jolla Pharmaceutical Company | $19.05 | 2020 | |
| Integra Lifesciences Corporation | $18.79 | 2021 | |
| Zyla Life Sciences, INC. | $14.55 | 2019 | |
| Boston Scientific Corporation | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Feher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.